GlassScriptPhysician profile
Sandeep Bajaj
NPI 1447254800
$16,066.30
in general payments reported to CMS, 2019-2025
53 companies · $4,016 in 2025
The $4,016 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,047 · 2020: $1,309 · 2021: $1,641 · 2022: $3,477 · 2023: $1,111 · 2024: $1,466 · 2025: $4,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,093 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,093.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $6,729.38 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,370.92 | 2019-2025 | |
| Amgen INC. | $936.41 | 2019-2025 | Repatha |
| Bard Peripheral Vascular, INC. | $835.20 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $514.18 | 2019-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $376.10 | 2022-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $344.76 | 2020-2025 | Nexletol |
| Heartflow, INC. | $323.40 | 2023-2025 | Ffrct |
| Merck Sharp & Dohme LLC | $288.23 | 2021-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $264.61 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $257.85 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.02 | 2019-2025 | Jardiance |
| Abbott Laboratories | $249.40 | 2022-2025 | Amplatzer Amulet, Xience Skypoint, Ensite Precision |
| Biotronik INC. | $247.87 | 2019-2022 | |
| Cardinal Health 200 LLC | $221.51 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $212.63 | 2019-2025 | Labosys |
| Sanofi-Aventis U.S. LLC | $186.74 | 2019-2023 | |
| Abiomed | $172.20 | 2024-2025 | Impella |
| Cordis US Corp. | $163.06 | 2021-2024 | Radial 360, Mynx Venous Vcd, Mynx Control |
| Atricure, INC. | $161.83 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cleerly, INC. | $152.87 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Actelion Pharmaceuticals US, INC. | $145.85 | 2022-2025 | Uptravi |
| Astrazeneca Pharmaceuticals LP | $141.78 | 2020-2024 | Farxiga |
| Medtronic Vascular, INC. | $135.41 | 2020 | |
| Impulse Dynamics (USA) INC. | $129.25 | 2023 | Optimizer |
| Gilead Sciences, INC. | $121.21 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.82 | 2019-2025 | |
| Amarin Pharma, INC. | $91.12 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $77.37 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $71.50 | 2021-2025 | Amvuttra |
| Siemens Medical Solutions USA, INC. | $68.82 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $61.78 | 2022-2023 | Arcalyst |
| Boston Scientific Corporation | $60.98 | 2019-2025 | Varithena Administration Pack, Avvigo Guidance System |
| Kiniksa Pharmaceuticals International, Plc | $60.85 | 2024 | Arcalyst |
| Elutia, INC. | $59.92 | 2021-2022 | |
| Tactile Systems Technology INC | $58.05 | 2021-2022 | |
| Bardy Diagnostics, INC. | $50.00 | 2019-2022 | |
| Medtronic, INC. | $38.31 | 2021-2023 | Venaseal |
| Regeneron Healthcare Solutions, INC. | $31.95 | 2019-2023 | Evkeeza |
| Novo Nordisk INC | $28.21 | 2021-2022 | |
| Edwards Lifesciences Corporation | $27.58 | 2019 | |
| Veryan Medical Incorporated | $27.40 | 2020 | |
| Biosense Webster, INC. | $22.52 | 2022 | |
| Glaxosmithkline, LLC. | $21.77 | 2025 | Arexvy, Shingrix |
| Lexicon Pharmaceuticals, INC. | $21.24 | 2023 | Inpefa |
| Braemar Manufacturing, LLC | $17.70 | 2019 | |
| Azurity Pharmaceuticals, INC. | $17.64 | 2025 | Edarbi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.50 | 2025 | Lifevest |
| Irhythm Technologies, INC. | $16.61 | 2023 | Zio Xt Patch |
| Acacia Pharma INC | $16.42 | 2021 | |
| Smith+Nephew, INC. | $16.04 | 2019 | |
| Daiichi Sankyo INC. | $13.86 | 2025 | Injectafer |
| Arbor Pharmaceuticals, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Bajaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.